GlobeNewswire 2021-12-01 Selecta Biosciences and Sobi Announce Completion of Enrollment in DISSOLVE Phase 3 Study Evaluating ...

GlobeNewswire 2021-10-15 Apellis and Sobi Receive Positive CHMP Opinion for Aspaveli® (pegcetacoplan) for the Treatment of PN...

GlobeNewswire 2021-09-07 Nature Medicine publishes positive phase 3 anakinra study results in patients with COVID-19 pneumoni...

GlobeNewswire 2021-07-08 Amolyt Pharma Announces Appointment of Two Directors

GlobeNewswire 2021-05-25 Apellis and Sobi Report Positive Top-line Results from the Phase 3 PRINCE Study of EMPAVELI™ (pegcet...

GlobeNewswire 2021-05-19 DBV Technologies Announces Results of its 2021 Ordinary and Extraordinary General Meeting and the Ap...

GlobeNewswire 2021-03-17 Apellis and Sobi: The New England Journal of Medicine Publishes Phase 3 PEGASUS Study Results Compar...

GlobeNewswire 2020-12-22 FDA Approves KINERET® (anakinra) for the Treatment of Deficiency of IL-1 Receptor Antagonist (DIRA)

GlobeNewswire 2020-12-10 Apellis and Sobi Report Positive Top-line Results at 48 Weeks from the Phase 3 PEGASUS Study of Pegc...

GlobeNewswire 2020-11-19 Apellis and Sobi Announce First Patient Dosed in Potentially Registrational ALS Study of Pegcetacopl...

GlobeNewswire 2020-11-02 Apellis Pharmaceuticals Reports Third Quarter 2020 Financial Results

GlobeNewswire 2020-10-27 Apellis and Sobi Enter Collaboration for Global Co-development and Ex-US Commercialization of System...

GlobeNewswire 2020-09-30 Selecta Biosciences and Sobi Announce Topline Data of SEL-212 from the Phase 2 COMPARE Trial Support...

GlobeNewswire 2020-09-23 First Patient Randomized in the Phase 3 DISSOLVE Clinical Program of SEL-212 for Chronic Refractory ...

GlobeNewswire 2020-09-16 FDA Granted Pediatric Disease Designation for OXi-4503

GlobeNewswire 2020-09-08 Selecta Biosciences to Participate in Upcoming Investor Conferences

GlobeNewswire 2020-09-01 Selecta Biosciences Secures Up To $35 Million Debt Financing with Oxford Finance LLC and Silicon Val...

GlobeNewswire 2020-08-03 Selecta Biosciences Appoints Peter G. Traber, MD as Chief Medical Officer

GlobeNewswire 2020-08-03 Selecta Biosciences to Participate in Upcoming Investor Conferences

GlobeNewswire 2020-07-30 Selecta Biosciences to Host Conference Call and Webcast to Discuss Second Quarter Financial Results ...

GlobeNewswire 2020-07-28 Sobi and Selecta announce closing of previously announced strategic licensing agreement for SEL-212,...

GlobeNewswire 2020-06-18 Sarepta Therapeutics and Selecta Biosciences Enter into Research License and Option Agreement for Se...

GlobeNewswire 2020-06-18 Sarepta Therapeutics and Selecta Biosciences Enter Into Research License and Option Agreement for Se...

GlobeNewswire 2020-06-15 Selecta Biosciences to Present at the Raymond James 2020 Human Healthcare Innovation Conference